Eli Lilly lifts 2020 forecast as coronavirus lockdowns fuel profit beat

Eli Lilly and Co raised the top-end of its 2020 profit forecast on Thursday and beat quarterly estimates, benefiting from customers stocking up medicines such as diabetes drug Trulicity amid the coronavirus pandemic.